Please login to the form below

Not currently logged in
Email:
Password:

Jeff Jonker joins Theravance

He has experience at Genentech
Theravance Jeff Jonker

Theravance has appointed Jeff Jonker as senior VP, corporate and business development.

He joins the US-based biopharma from Satori where he served as chief business officer.

In his new role, he will report to Theravance CEO Rick Winningham and will hold responsibility for managing the company's business and corporate development affairs.

Prior to joining Satori, Jonker held senior roles at Genentech and Gloucester Pharmaceuticals.

"Jeff brings a wealth of industry and deal experience to Theravance,” said Winningham.

The CEO also commented that Jonkers' appointment will support the companys' plans to split into two biotech groups as its deals with GlaxoSmithKline are advanced.

“As Theravance separates into two companies, Jeff's track record of building successful companies and establishing strong collaborations will be important to our future growth,” said Winningham.

4th November 2013

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics